Free Trial

Vontier (VNT) Competitors

Vontier logo
$37.51 +0.30 (+0.80%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VNT vs. AVTR, RVTY, BIO.B, NVMI, ST, CAMT, MIR, TXG, TRNS, and CTKB

Should you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Camtek (CAMT), Mirion Technologies (MIR), 10x Genomics (TXG), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

Vontier vs.

Avantor (NYSE:AVTR) and Vontier (NYSE:VNT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Avantor has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Vontier has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

Vontier has a net margin of 13.54% compared to Avantor's net margin of 4.54%. Vontier's return on equity of 45.48% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor4.54% 12.24% 5.15%
Vontier 13.54%45.48%10.49%

In the previous week, Vontier had 1 more articles in the media than Avantor. MarketBeat recorded 12 mentions for Vontier and 11 mentions for Avantor. Avantor's average media sentiment score of 0.60 beat Vontier's score of 0.37 indicating that Avantor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Vontier
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.1% of Avantor shares are held by institutional investors. Comparatively, 95.8% of Vontier shares are held by institutional investors. 1.3% of Avantor shares are held by company insiders. Comparatively, 0.8% of Vontier shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Avantor received 140 more outperform votes than Vontier when rated by MarketBeat users. Likewise, 65.12% of users gave Avantor an outperform vote while only 51.81% of users gave Vontier an outperform vote.

CompanyUnderperformOutperform
AvantorOutperform Votes
183
65.12%
Underperform Votes
98
34.88%
VontierOutperform Votes
43
51.81%
Underperform Votes
40
48.19%

Vontier has lower revenue, but higher earnings than Avantor. Vontier is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.97B2.14$321.10M$0.4647.55
Vontier$2.99B1.89$376.90M$2.6114.40

Avantor currently has a consensus price target of $27.38, indicating a potential upside of 25.19%. Vontier has a consensus price target of $44.63, indicating a potential upside of 18.73%. Given Avantor's stronger consensus rating and higher possible upside, equities analysts clearly believe Avantor is more favorable than Vontier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.77
Vontier
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63

Summary

Avantor beats Vontier on 11 of the 18 factors compared between the two stocks.

Get Vontier News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VNT vs. The Competition

MetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE Exchange
Market Cap$5.65B$6.00B$7.65B$19.95B
Dividend Yield0.28%0.47%2.34%3.71%
P/E Ratio14.4033.9328.0141.51
Price / Sales1.895.45437.6817.17
Price / Cash9.5630.0229.1419.82
Price / Book6.489.376.245.75
Net Income$376.90M$234.75M$133.93M$994.45M
7 Day Performance4.55%4.20%1.68%3.27%
1 Month Performance-1.46%-3.21%4.00%2.00%
1 Year Performance10.84%27.76%26.01%19.66%

Vontier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VNT
Vontier
3.8925 of 5 stars
$37.51
+0.8%
$44.63
+19.0%
+9.0%$5.63B$2.99B14.378,000Short Interest ↓
AVTR
Avantor
4.0199 of 5 stars
$22.10
+2.0%
$27.69
+25.3%
+3.5%$15.04B$6.82B48.0414,500Analyst Forecast
Options Volume
News Coverage
High Trading Volume
RVTY
Revvity
3.594 of 5 stars
$122.76
+7.8%
$131.93
+7.5%
+10.4%$14.94B$2.72B59.3011,500
BIO.B
Bio-Rad Laboratories
N/A$341.00
flat
N/A+7.5%$9.55B$2.58B-12.488,200
NVMI
Nova
1.7939 of 5 stars
$217.85
+0.1%
$238.33
+9.4%
+81.4%$6.33B$611.85M40.643,606Analyst Revision
News Coverage
ST
Sensata Technologies
4.734 of 5 stars
$27.44
+0.7%
$41.00
+49.4%
-17.4%$4.10B$4.02B-50.8120,800Analyst Forecast
News Coverage
CAMT
Camtek
3.7929 of 5 stars
$86.79
-3.0%
$110.78
+27.6%
+33.6%$3.94B$400.63M40.00400Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
Gap Up
MIR
Mirion Technologies
2.7832 of 5 stars
$15.89
flat
$19.25
+21.1%
+69.2%$3.69B$836.90M-46.743,000Gap Down
TXG
10x Genomics
4.5739 of 5 stars
$15.71
+0.8%
$23.86
+51.9%
-66.1%$1.90B$629.74M-10.271,240News Coverage
Gap Up
TRNS
Transcat
3.134 of 5 stars
$103.49
+0.9%
$130.25
+25.9%
+6.3%$952.01M$270.61M52.27920
CTKB
Cytek Biosciences
2.737 of 5 stars
$7.21
+5.7%
$9.25
+28.3%
-31.5%$928.73M$201.21M-90.11500News Coverage
Positive News

Related Companies and Tools


This page (NYSE:VNT) was last updated on 1/17/2025 by MarketBeat.com Staff
From Our Partners